Sayonara Novartis: Ex-cell therapy chief challenges CAR-T leaders, moves to Carl June’s biotech startup
Three months after Novartis declared its big biotech experiment in cell therapies kaput and dissolved the 400-person unit, its former chief has now jumped ship to run a cell therapy upstart which he is already intimately familiar with.
Usman ‘Oz’ Azam has taken the helm of Tmunity Therapeutics in Philadelphia, which was founded by one of Penn’s star scientists, Carl June, with an eye to developing new, curative cell therapies. It launched in January with $10 million in backing from Penn Medicine, the academic medical center of the University of Pennsylvania, and Lilly Asia Ventures.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
